This week, five Medical Devices stocks are improving their overall ratings on . Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Derma Sciences (NASDAQ:) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Derma Sciences markets and sells a range of skin care, wound management, and specialty securement devices. In Portfolio Grader’s specific subcategories of Earnings Revisions and Sales Growth, DSCI also gets A’s. .
GenMark Diagnostics (NASDAQ:) gets a higher grade this week, advancing from a B last week to a A. GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. .
Rochester Medical (NASDAQ:) is seeing ratings go up from a B last week to a A this week. Rochester Medical develops, manufactures and markets latex free disposable urinary continence care products.
.
The rating of West Pharmaceutical Services (NYSE:) moves up this week, rising from a B to a A. West Pharmaceutical is a manufacturer of components and systems for injectable drug delivery, and plastic packaging and delivery system components for the healthcare and consumer products industries. .
Exactech (NASDAQ:) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Exactech develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. .
Louis Navellier’s proprietary stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool .
